Given the central role of NRF2 in oxidative stress response and inflammation, its activation by HRG in the context of angiogenesis opens up potential therapeutic avenues beyond cancer, including chronic inflammatory diseases in which pathological angiogenesis plays a key role. Here, NFE2L2 is linked to cancer.